UNITAID is in talks with makers of AIDS drugs about a patent pool

07/21/2010 | Reuters

UNITAID is in advanced negotiations with Merck & Co., Gilead Sciences and Johnson & Johnson subsidiary Tibotec about licensing their AIDS treatments to generic-drug makers in developing nations, through a patent pool. The health-funding agency singled out 19 drugs from nine companies for possible inclusion in the pool.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN